$微软(MSFT)$ 在科技股板块剧烈轮动的浪潮中，微软再度展现了其作为定海神针的绝对实力。微软最核心的长线投资逻辑在于其无人能及的市场垄断性强。无论是全球企业赖以生存的 Windows 操作系统、Office 办公套件，还是高速增长的 Azure 云端基础设施，都已经深深嵌入全球数位经济的骨髓。 这种强大的主导地位，赋予了微软无与伦比的定价权，使其现金流极其稳定且充裕。即使面临 AI 转型期高昂的资本支出，微软依然能气定神闲地面对，完全不需背负债务压力。微软就是一家一直在帮你稳定印钞的「数位地主」，趁大盘震荡时逢低分批吸纳，是锁定未来财富的核心资产。
ARKK Investment Tracker position change: Decreased position in Pacific Biosciences of California by 385,212 shares, the number of shares held decreased 2.71% compared to the previous period and now represents 0.31% of the total position.
ARKK Investment Tracker position change: Decreased position in Alphabet by 2,538 shares, the number of shares held decreased 2.67% compared to the previous period and now represents 0.55% of the total position.
ARKK Investment Tracker position change: Decreased position in BWX Technologies Inc by 7,661 shares, the number of shares held decreased 2.7% compared to the previous period and now represents 0.92% of the total position.
$微软(MSFT)$ 在科技股板块剧烈轮动的浪潮中，微软再度展现了其作为定海神针的绝对实力。微软最核心的长线投资逻辑在于其无人能及的市场垄断性强。无论是全球企业赖以生存的 Windows 操作系统、Office 办公套件，还是高速增长的 Azure 云端基础设施，都已经深深嵌入全球数位经济的骨髓。 这种强大的主导地位，赋予了微软无与伦比的定价权，使其现金流极其稳定且充裕。即使面临 AI 转型期高昂的资本支出，微软依然能气定神闲地面对，完全不需背负债务压力。微软就是一家一直在帮你稳定印钞的「数位地主」，趁大盘震荡时逢低分批吸纳，是锁定未来财富的核心资产。
ARKK Investment Tracker position change: Decreased position in Pacific Biosciences of California by 385,212 shares, the number of shares held decreased 2.71% compared to the previous period and now represents 0.31% of the total position.
ARKK Investment Tracker position change: Decreased position in Kratos Defense & Security Solutions by 30,456 shares, the number of shares held decreased 2.71% compared to the previous period and now represents 0.96% of the total position.
ARKX Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 2,046 shares, the number of shares held decreased 5.26% compared to the previous period and now represents 2.17% of the total position.
ARKX Investment Tracker position change: Decreased position in Kratos Defense & Security Solutions by 61,413 shares, the number of shares held decreased 5.29% compared to the previous period and now represents 7.59% of the total position.
ARKK Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 3,995 shares, the number of shares held decreased 2.69% compared to the previous period and now represents 1.08% of the total position.
ARKK Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 558,360 shares, the number of shares held decreased 2.71% compared to the previous period and now represents 1.05% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 39,516 shares, the number of shares held increased 0.39% compared to the previous period and now represents 1.01% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 45,522 shares, the number of shares held increased 0.39% compared to the previous period and now represents 2.7% of the total position.
ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 7,389 shares, the number of shares held increased 0.39% compared to the previous period and now represents 2.38% of the total position.
ARKX Investment Tracker position change: Decreased position in L3Harris Technologies, Inc. by 12,573 shares, the number of shares held decreased 5.28% compared to the previous period and now represents 8.47% of the total position.
ARKX Investment Tracker position change: Decreased position in Palantir Technologies Inc. by 12,045 shares, the number of shares held decreased 5.28% compared to the previous period and now represents 3.53% of the total position.
ARKK Investment Tracker position change: Decreased position in Palantir Technologies Inc. by 38,352 shares, the number of shares held decreased 2.71% compared to the previous period and now represents 2.87% of the total position.
ARKK Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 182,783 shares, the number of shares held decreased 2.71% compared to the previous period and now represents 3.63% of the total position.
ARKK Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 169,341 shares, the number of shares held decreased 2.71% compared to the previous period and now represents 5.33% of the total position.
ARKK Investment Tracker position change: Decreased position in SoFi Technologies Inc. by 56,776 shares, the number of shares held decreased 2.71% compared to the previous period and now represents 0.59% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 14,612 shares, the number of shares held decreased 0.52% compared to the previous period and now represents 3.12% of the total position.
ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 17,298 shares, the number of shares held increased 3.62% compared to the previous period and now represents 0.51% of the total position.